Evidence map›Paper›PMID 36304975›Full record

ArticleMaterials today. Bio2022

Macromolecular assembly of bioluminescent protein nanoparticles for enhanced imaging.

Enya Li, Caroline K Brennan, Aaron Ramirez, Jo A Tucker, Nina Butkovich, Vijaykumar S Meli, Anastasia A Ionkina, Edward L Nelson, Jennifer A Prescher, Szu-Wen Wang

Abstract read
In one paragraph

Article in Materials today. Bio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Optical and Photoacoustic Imaging.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Enya LiDepartment of Chemical & Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.
Caroline K BrennanDepartment of Chemistry, University of California, Irvine, CA, 92697, USA.
Aaron RamirezDepartment of Chemical & Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.
Jo A TuckerDepartment of Medicine, University of California, Irvine, CA, 92697, USA.
Nina ButkovichDepartment of Chemical & Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.
Vijaykumar S MeliDepartment of Chemical & Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.
Anastasia A IonkinaDepartment of Molecular Biology & Biochemistry, University of California, Irvine, CA, 92697, USA.
Edward L NelsonDepartment of Medicine, University of California, Irvine, CA, 92697, USA.
Jennifer A PrescherDepartment of Chemistry, University of California, Irvine, CA, 92697, USA.
Szu-Wen WangDepartment of Chemical & Biomolecular Engineering, University of California, Irvine, CA, 92697, USA.

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
CARCINOGENESIST32CA009054 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI EDINGER, AIMEE L, FRUMAN, DAVID ALEXANDER · 1985 to 2025
$8.6M
Tumor-Associated Antigen Delivery using Protein Nanoparticles for Combined ImmunotherapyR01EB027797 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI WANG, SZU-WEN · 2019 to 2022
$1.3M
NCI NIH HHS P30 CA062203NCI NIH HHS T32 CA009054NIBIB NIH HHS R01 EB027797
6 · The paper itself

Abstract

Bioluminescence imaging has advantages over fluorescence imaging, such as minimal photobleaching and autofluorescence, and greater signal-to-noise ratios in many complex environments. Although significant achievements have been made in luciferase engineering for generating bright and stable reporters, the full capability of luciferases for nanoparticle tracking has not been comprehensively examined. In biocatalysis, enhanced enzyme performance after immobilization on nanoparticles has been reported. Thus, we hypothesized that by assembling luciferases onto a nanoparticle, the resulting complex could lead to substantially improved imaging properties. Using a modular bioconjugation strategy, we attached NanoLuc (NLuc) or Akaluc bioluminescent proteins to a protein nanoparticle platform (E2), yielding nanoparticles NLuc-E2 and Akaluc-E2, both with diameters of ∼45 ​nm. Although no significant differences were observed between different conditions involving Akaluc and Akaluc-E2, free NLuc at pH 5.0 showed significantly lower emission values than free NLuc at pH 7.4. Interestingly, NLuc immobilization on E2 nanoparticles (NLuc-E2) emitted increased luminescence at pH 7.4, and at pH 5.0 showed over two orders of magnitude (>200-fold) higher luminescence (than free NLuc), expanding the potential for imaging detection using the nanoparticle even upon endocytic uptake. After uptake by macrophages, the resulting luminescence with NLuc-E2 nanoparticles was up to 7-fold higher than with free NLuc at 48 ​h. Cells incubated with NLuc-E2 could also be imaged using live bioluminescence microscopy. Finally, biodistribution of nanoparticles into lymph nodes was detected through imaging using NLuc-E2, but not with conventionally-labeled fluorescent E2. Our data demonstrate that NLuc-bound nanoparticles have advantageous properties that can be utilized in applications ranging from single-cell imaging to

Indexed as

Akaluc luciferaseBioluminescenceIn vitro imagingIn vivo imagingNanoLuc luciferaseNanoparticle

Identifiers

PMID36304975
PMCPMC9593766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.